Pardeep Nijhawan - 02 Nov 2022 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Pardeep Nijhawan
Issuer symbol: EDSA
Transactions as of: 02 Nov 2022
Net transactions value: +$513,590
Form type: 4
Filing time: 04 Nov 2022, 15:27:05 UTC
Previous filing: 05 Jul 2022
Next filing: 24 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDSA	Common Shares	Award	$256,795	+228,262	+11%	$1.12	2,356,914	02 Nov 2022	Held by Pardeep Nijhawan Medicine Professional Corporation	F1, F2
transaction	EDSA	Common Shares	Award	$256,795	+228,262		$1.12	228,262	02 Nov 2022	By Trust	F1
holding	EDSA	Common Shares						594,812	02 Nov 2022	Direct
holding	EDSA	Common Shares						224,094	02 Nov 2022	Held by The Digestive Health Clinic Inc.	F2
holding	EDSA	Common Shares						371,727	02 Nov 2022	Held by 1968160 Ontario Inc.	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EDSA	Common Share Warrants (Right to Buy)	Award		+114,131			114,131	02 Nov 2022	Common Shares	114,131	$1.50	Held by Pardeep Nijhawan Medicine Professional Corporation	F1, F2, F3
transaction	EDSA	Common Share Warrants (Right to Buy)	Award		+114,131			114,131	02 Nov 2022	Common Share	114,131	$1.50	By Trust	F1, F3
transaction	EDSA	Common Share Warrants (Right to Buy)	Award		+114,131			114,131	02 Nov 2022	Common Shares	114,131	$1.00	Held by Pardeep Nijhawan Medicine Professional Corporation	F1, F2, F4
transaction	EDSA	Common Share Warrants (Right to Buy)	Award		+114,131			114,131	02 Nov 2022	Common Share	114,131	$1.00	By Trust	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share.
F2	Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan.
F3	Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date.
F4	Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date.